The Benecon Group names new chief commercial officer

Benecon Group has appointed Michael Sullivan as Chief Commercial Officer as it looks to accelerate national growth of its self-funded consortium platform, VERIS.

Sullivan, a veteran healthcare executive with over 25 years of experience, previously held senior roles at Independence Health Group, AmeriHealth Administrators, and Highmark. He brings expertise in stop-loss, TPA operations, product strategy, and distribution—experience well-aligned with Benecon’s ambitions for national scale.

VERIS, Benecon’s independent consortium solution, is designed to offer employers greater control, cost predictability, and purchasing power in self-funded healthcare. With more than a decade of actuarial data and underwriting discipline behind it, the platform is entering its next phase of commercial expansion.

Sullivan will lead go-to-market execution, including advisor engagement, channel strategy, and regional expansion. His appointment reflects Benecon’s focus on scaling operations and deepening distribution as demand for self-funded solutions grows.

TA Associates, Benecon’s private equity partner, backed the move, calling it a strategic step toward category leadership.